FDA-cleared profile

Aplio i900/i800/i700 Diagnostic Ultrasound System, Software V7.0 (TUS-AI900, TUS-AI800, TUS-AI700)

Canon Medical Systems Corporation

Aplio i900/i800/i700 V7.0 is a mobile diagnostic ultrasound system with supported body and cardiac clinical applications and imaging modes for trained physicians and legally qualified users.

Evidence status: each field shows source quality, applicability, and review date. Research pending, information not established in reviewed sources, and vendor documentation pending are distinct outcomes.

Clinical fit

What this tool is for

Start with the authorized purpose, then verify how it fits your service line and reading workflow.

Exact purpose
Aplio i900/i800/i700 V7.0 is a mobile diagnostic ultrasound system with supported body and cardiac clinical applications and imaging modes for trained physicians and legally qualified users.
FDA source Exact FDA submission Checked 2026-09-04
Intended users
Physicians or other legally qualified persons who have received appropriate training; the validation references clinical sonographers representative of intended U.S. users for the cardiac workflow features.
FDA source Exact FDA submission Checked 2026-09-04
Care setting and population
Hospitals, clinics, and other clinical ultrasound settings supported by the configured system and transducers.
FDA source Exact FDA submission Checked 2026-09-04

Prior source-backed dossier value: Hospital and clinical environments performing diagnostic ultrasound, including cardiac ultrasound workflows.

Workflow role
Supports diagnostic ultrasound acquisition and review across standard imaging modes. Auto Plane Detection selects candidate cardiac views; Quick Strain launches left-ventricular wall-motion tracking for three apical views; Auto LVOT and Auto AoV trace Doppler waveforms to reduce manual tracing time; right-ventricular and right-atrial wall-motion tracking are also added.
FDA source Exact FDA submission Checked 2026-09-04
Required input
Ultrasound images and Doppler waveforms acquired on compatible Aplio i900, i800, or i700 systems using supported linear, convex, and sector probes operating at approximately 2 to 33 MHz; the cardiac automation features use supported chamber views or LVOT and aortic-valve waveforms.
FDA source Exact FDA submission Checked 2026-09-04
Output and human action
Diagnostic ultrasound images and measurements plus feature-specific candidate cardiac-view selection, wall-motion-tracking results including EDV, ESV, EF, and GLS, and automatically traced LVOT or aortic-valve Doppler measurements for qualified-user review.
FDA source Exact FDA submission Checked 2026-09-04
Limitations
The cardiac automation features support rather than replace trained-user review. FDA-reported validation used previously acquired data from one U.S. clinical site, with 50 selected patients for Auto Plane Detection and Quick Strain and 45 for each Doppler-tracing evaluation; the summary does not report prospective clinical outcomes or multisite validation.
FDA source Exact FDA submission Checked 2026-09-04

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K241582
FDA source Exact FDA submission Checked 2026-08-31
Modality
Ultrasound
FDA source Exact FDA submission Checked 2026-09-04
Anatomy
Multi-region
FDA source Exact FDA submission Checked 2026-09-04
Clearance type
510(k)
FDA source Exact FDA submission Checked 2026-08-31
Decision date
2024-09-12
FDA source Exact FDA submission Checked 2026-08-31
FDA status
FDA-cleared
FDA source Exact FDA submission Checked 2026-08-31

Implementation

Questions for IT, informatics, and operations

Use these fields to structure a vendor demo, security review, and implementation estimate.

Integration
The FDA material describes the configured ultrasound console, clinical applications, supported probes and modes, and the system's measurement and review workflow.
FDA source Exact FDA submission Checked 2026-09-04

This is the interface boundary described in the exact FDA decision material; current local compatibility, routing, identity, archive, and downtime behavior still require acceptance testing. Prior source-backed dossier value: The system is an on-premises ultrasound platform with site-network image exchange. Canon's current interoperability page lists an IHE integration statement for Aplio i700, i800, and i900 software V6.0 or later, covering the V7.0 lineage.

Deployment and data flow
The FDA material describes a mobile diagnostic ultrasound console; current room, network, archive, service, security, and enabled-option configuration remain unverified.
FDA source Exact FDA submission Checked 2026-09-04

This is the release-level boundary described in the exact FDA decision material; current hosting, contracts, security, availability, upgrade path, and site configuration remain separate evidence. Prior source-backed dossier value: On-premises mobile Aplio i900, i800, or i700 ultrasound console running the K241582 software V7.0 configuration.

Security and privacy
Not established in reviewed sources
Reviewed sources checked Exact FDA submission Checked 2026-09-04

Public materials reviewed for this exact release do not establish the complete security posture. Request data-flow, identity, audit, encryption, retention, remote-access, vulnerability-management, backup, and incident-response evidence.

Training and support
Only Trained physicians and legally qualified healthcare professionals operating supported diagnostic ultrasound applications should operate or interpret the product; local onboarding must cover the exact release, supported population, limitations, failure examples, escalation, downtime, and competency documentation.
FDA source Exact FDA submission Checked 2026-09-04
Monitoring and change control
Monitor K241582 by exact hardware, software, model, algorithm version, patient population, anatomy, protocol, operator, input quality, output edits or overrides, failed studies, repeat acquisition or rework, downstream impact, downtime, incidents, recalls, and updates. Track these product-specific limits: Supported applications, probes, modes, patient populations, image quality, and exact system configuration limit use; trained professionals retain responsibility for interpretation.
FDA source Exact FDA submission Checked 2026-09-04

Buyer-facing monitoring guidance derived from the exact cleared scope; it is not a claim that the FDA package provides a live monitoring service.

Cardiac automation package

Auto Plane Detection, Quick Strain, Auto LVOT, and Auto AoV automate candidate-view selection, wall-motion-tracking launch, and Doppler waveform tracing; the submission also adds right-ventricular and right-atrial wall-motion tracking.

exact submission · checked 2026-09-02

Confirm licensed features, supported probes and presets, user-editing behavior, and report transfer for the purchased configuration.

Supported platform

Mobile Aplio i900, i800, and i700 systems with compatible probes spanning approximately 2 to 33 MHz and standard diagnostic ultrasound imaging modes.

exact submission · checked 2026-09-02

Verify exact model, transducer, option, and software-build compatibility.

IHE integration documentation

Canon's current interoperability page lists an IHE integration statement for Aplio i700, i800, and i900 software V6.0 or later.

exact product version · checked 2026-09-02

Obtain and test the statement corresponding to the exact installed software build.

Deployment model

Mobile, on-premises diagnostic ultrasound console.

exact submission · checked 2026-09-02

Site preparation, cybersecurity controls, service access, updates, training, and downtime planning require current vendor documentation.

Release and scope verification

Map installed model, build, options, population, anatomy, inputs, outputs, and enabled functions to K241582 before acceptance.

exact submission · checked 2026-09-04

Later product-family features are not evidence that this cleared release includes them.

Deployment boundary

The FDA material describes a mobile diagnostic ultrasound console; current room, network, archive, service, security, and enabled-option configuration remain unverified.

exact submission · checked 2026-09-04

FDA-described deployment boundaries do not establish current hosting contracts, security controls, uptime, or local qualification.

Interoperability acceptance

The FDA material describes the configured ultrasound console, clinical applications, supported probes and modes, and the system's measurement and review workflow.

exact submission · checked 2026-09-04

Test representative identifiers, orientation, geometry, measurements, units, routing, failure handling, and round trips locally.

Clinical acceptance

Use a signed local test set for the supported population and workflow. Include common and difficult cases, exclusions, acquisition variation, failed or low-quality inputs, reviewer overrides, and downstream effects. Supported applications, probes, modes, patient populations, image quality, and exact system configuration limit use; trained professionals retain responsibility for interpretation.

exact submission · checked 2026-09-04

Define stop-use, escalation, rollback, and revalidation triggers before production use.

Economic evaluation

Model capital and recurring cost against net staff time after review, throughput, repeat imaging or rework, room time, consumables, infrastructure, training, service, downtime, upgrade, and replacement costs.

product family · checked 2026-09-04

No exact-product price was found in the reviewed public material; productivity or value claims require local evidence.

Lifecycle monitoring

Monitor K241582 by exact hardware, software, model, algorithm version, patient population, anatomy, protocol, operator, input quality, output edits or overrides, failed studies, repeat acquisition or rework, downstream impact, downtime, incidents, recalls, and updates.

exact submission · checked 2026-09-04

Revalidate after material software, hardware, model, protocol, interface, or clinical-policy changes.

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version.

Evidence summary
Manufacturer-sponsored validation used locked, sequestered test data from one U.S. clinical site and three licensed sonographers for truthing. The reported results establish feature-level agreement and workflow time reduction, not improved patient outcomes.
FDA source Exact FDA submission Checked 2026-09-04
Reported sensitivity
Not applicable
Not applicable Not applicable Checked 2026-09-04

Sensitivity is not promoted as a product-wide endpoint. Compare only an exact endpoint, threshold, population, version, and source if later verified.

Reported specificity
Not applicable
Not applicable Not applicable Checked 2026-09-04

Specificity is not promoted as a product-wide endpoint. Compare only an exact endpoint, threshold, population, version, and source if later verified.

Auto Plane Detection average pass rate

97 % across four cardiac views

Average pass rate for agreement with sonographer-selected A4C, A3C, A2C, and SAX views; each view was required to exceed 90% agreement in Representative images from 50 U.S. patients selected from 239 patients acquired at one U.S. clinical site.

Tested version: K241582 Auto Plane Detection on Aplio i900, i800, and i700 software V7.0

Quick Strain operation-time reduction

68 % average reduction

Average reduction in operation time versus conventional three-view wall-motion tracking while meeting ICC and EDV, ESV, EF, and GLS equivalence criteria in Representative images from 50 U.S. patients selected from 239 patients acquired at one U.S. clinical site.

Tested version: K241582 Quick Strain on Aplio i900, i800, and i700 software V7.0

Auto LVOT operation-time reduction

78 % average reduction

Average reduction in operation time for three consecutive heart cycles versus manual LVOT Doppler tracing while meeting ICC and NRMSE criteria in Representative images from 45 U.S. patients selected from 239 patients acquired at one U.S. clinical site.

Tested version: K241582 Auto LVOT on Aplio i900, i800, and i700 software V7.0

Auto AoV operation-time reduction

71 % average reduction

Average reduction in operation time for three consecutive heart cycles versus manual aortic-valve Doppler tracing while meeting ICC and NRMSE criteria in Representative images from 45 U.S. patients selected from 239 patients acquired at one U.S. clinical site.

Tested version: K241582 Auto AoV on Aplio i900, i800, and i700 software V7.0

K241582 Auto Plane Detection and Quick Strain validation

Manufacturer-sponsored retrospective feature validation using sequestered test images and three licensed sonographers for ground truth · 50 selected patients with ages 20 to 98 years, balanced sex, BMI 16.4 to 71.6 kg/m2, and multiple ejection-fraction severity categories; source pool contained 239 patients from one U.S. site

exact submission · Tested version: K241582 Auto Plane Detection and Quick Strain on software V7.0 · n=50 · 1 site · Sponsor or vendor study

K241582

The test data were independent of training data, but the study was manufacturer-sponsored and did not evaluate patient outcomes.

K241582 Auto LVOT and Auto AoV validation

Manufacturer-sponsored retrospective Doppler-tracing workflow validation using sequestered test images and three licensed sonographers for ground truth · 45 selected patients with ages 36 to 89 years, BMI 18.8 to 71.6 kg/m2, and representative Doppler severity categories; source pool contained 239 patients from one U.S. site

exact submission · Tested version: K241582 Auto LVOT and Auto AoV on software V7.0 · n=45 · 1 site · Sponsor or vendor study

K241582

Age and sex were unavailable for some anonymized cases. The study did not evaluate prospective workflow or patient outcomes.

Economics and lifecycle

Budget and ongoing governance

These are common procurement questions; unknown values remain visible until a source supports them.

Pricing and total cost
Not established in reviewed sources
Reviewed sources checked Exact FDA submission Checked 2026-09-04

No public list price for the exact cleared configuration was found. Obtain a written quote separating hardware or license basis, implementation, interfaces, infrastructure, training, service, upgrades, renewal, consumables, and exit costs.

Reimbursement and coding
No separate named-product Medicare payment was identified in the reviewed CMS coverage material. Evaluate the product within the applicable imaging or clinical service line and verify payer, site-of-service, coding, and coverage assumptions independently.
Public source Not applicable Checked 2026-09-04

No product-specific code

No separate named-product payment identified in reviewed public material

Centers for Medicare & Medicaid Services · United States

This is not a product-specific reimbursement determination. Verify payer, site-of-service, coding, and coverage assumptions independently.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
The 2026-09-02 openFDA device-recall snapshot contained no record matched to K241582 by exact native submission identifier. This does not exclude product-family, later-version, or adverse-event information.
Public source Exact FDA submission Checked 2026-09-04

Exact-identifier review does not prove absence of all product-family safety signals.

Buyer worksheet

Open questions to take to the vendor

Open evaluation checklist

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-04Last searched
32Fields reviewed
11Source classes checked
20Reviewed PubMed leads
10Reviewed trial leads
0Unreviewed FDA recall leads

Screened 20 PubMed and 10 ClinicalTrials.gov records. They concern Aplio i700, i800, or i900 hardware and other ultrasound studies but do not identify the K241582 software V7.0 configuration as tested; all 30 were quarantined and none was promoted. The current discovery snapshot contains 20 PubMed and 10 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, fda decision material, peer reviewed literature, clinical trial registry, reimbursement policy, fda device recall, vendor interoperability, pubmed, clinical trials, openfda device recall

Sources

Source ledger

Sources accessed through 2026-09-04.

Alternatives

Related tools to compare

FDA-cleared K251963

LOGIQ E10s

Ge Medical Systems Ultrasound and Primary Care Diagnostics

LOGIQ E10s is a general-purpose diagnostic ultrasound system supporting the labeled adult, pediatric, cardiac, vascular, abdominal, obstetric, small-organ, musculoskeletal,...

Modality
Ultrasound
Anatomy
Multi-region
Decision
2025-10-29
FDA-cleared K251985

LOGIQ E10

Ge Medical Systems Ultrasound and Primary Care Diagnostics

LOGIQ E10 is a general diagnostic ultrasound system for qualified users across fetal and obstetric, abdominal, gynecologic, pediatric, small-organ, breast, cardiac, vascular,...

Modality
Ultrasound
Anatomy
Multi-region
Decision
2025-10-29
FDA-cleared K250999

V8 Diagnostic Ultrasound System; cV8 Diagnostic Ultrasound System; V7 Diagnostic Ultrasound System; cV7 Diagnostic Ultrasound System; V6 Diagnostic Ultrasound System; cV6 Diagnostic Ultrasound System; V5 Diagnostic Ultrasound System; cV5 Diagnostic Ultrasound System; V4 Diagnostic Ultrasound System; cV4 Diagnostic Ultrasound System

Samsung Medison Co., Ltd.

The Samsung V-family diagnostic ultrasound systems support fetal and obstetric, abdominal, gynecologic, pediatric, small-organ, cephalic, cardiac, thoracic, vascular,...

Modality
Ultrasound
Anatomy
Multi-region
Decision
2025-07-18